EAV / Voll — Electroacupuncture According to Voll

Electroacupuncture According to Voll (EAV), developed by Reinhold Voll in 1950s Germany, reads the electrical resistance of the skin at acupuncture points and treats the reading as a diagnosis of organ disease. It sits in the Electroceuticals / Bioelectronic Medicine family, and it is the atlas's textbook case of a single, load-bearing distinction: the instrument is not the interpretation. The hardware measures something real; the diagnostic story laid over that measurement is what failed.

The real substrate — a genuine electrodermal measurement

Strip away the doctrine and what remains is ordinary, working instrumentation. An EAV or Dermatron-type point meter is a voltmeter and ammeter applying a small voltage across the skin and recording the current that flows. Skin impedance is a real, physical quantity — it varies with moisture, pressure, and contact — and the device records it as real data. There is nothing fictional about the act of measuring electrodermal resistance; the question the atlas keeps explicitly open is whether any valid, modern interpretation of that electrodermal signal exists. That open question is the “keep” half of this entry.

Claim vs evidence — why grade F

The claim is specific and falsifiable: that the impedance read at a given point diagnoses disease in a corresponding organ, and can be matched to a remedy. That specificity is what makes it testable — and it is exactly where the method breaks. Under blinding, EAV operators perform no better than chance: the readings do not track the conditions they are said to detect. This is not “no evidence yet” but tested-and-contradicted, which is what grade F records. The diagnostic interpretation, not the voltmeter, is what failed. A review in The Lancet Oncology situates this class of unconventional diagnostics and their testing record (Lancet Oncology, 2000).

Why this tier — and the “tested, not confirmed” sub-state

EAV sits in the Not-confirmed tier under the tested — not confirmed sub-badge, and the distinction matters. This is not a device whose hardware is fictional or whose physics is incoherent; it is a real instrument whose interpretation was put to the test and did not survive. Keep the three axes apart. The instrument's plausibility is fine — it genuinely measures impedance. The plausibility of the diagnostic claim is low — chance-level under blinding. The grade is F for that claim. A working voltmeter does not rescue a diagnosis that fails testing, and a failed diagnosis does not make the voltmeter imaginary. Tier, grade, and plausibility are independent axes here, and reading them together is the whole point.

Regulatory — no diagnostic standing anywhere

No jurisdiction grants EAV standing as a validated diagnostic. In the US it has no accepted standing and is not cleared for organ or allergy diagnosis; in the EU there is no diagnostic clearance, and the devices circulate in the alternative-practitioner market; no diagnostic clearance has been identified in Russia, China, or Australia. There is nothing to convert here from market access to efficacy — even the market-access fact is absent for the diagnostic claim.

Lineage — the Abrams-era root

EAV descends from the early twentieth-century radionics tradition traced on the lineage page — the Abrams-era idea that disease has an electrical signature a device can read. Vega testing is its direct descendant, Schimmel's 1970s modification that puts coded ampoules into the same kind of circuit; the two share one electrodermal substrate. The shared root is what makes the family resemblance more than coincidence.

Keep vs set aside

Keep: the voltmeter, the ammeter, and the electrodermal measurement itself — real instrumentation producing real data — together with the genuinely open question of whether a valid, modern reading of skin-impedance data exists. That is the honest reinterpretation this entry insists on: the failure was of one specific interpretation, not of the act of measuring. Set aside: the claim that point-impedance readings diagnose specific organ disease or select remedies. That interpretation was tested under blinding, was not confirmed, and is rejected — while the instrument and its raw signal remain, awaiting a question they can actually answer.